CAILA NUNES: Open Payments
NPI 1922709245 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 97 payments from 12 companies in 2025. Trend: 2023 $970 · 2024 $2,233 · 2025 $2,167
Food & beverage: $1,984Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $728 |
| Regeneron Healthcare Solutions, Inc. | 8 | $355 |
| Janssen Biotech, Inc. | 14 | $338 |
| GENZYME CORPORATION | 4 | $163 |
| Amgen Inc. | 3 | $145 |
| Galderma Laboratories, L.P. | 2 | $129 |
| E.R. Squibb & Sons, L.L.C. | 3 | $84 |
| Organon LLC | 4 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $60 |
| Incyte Corporation | 2 | $45 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, RINVOQ, OTEZLA, NEMLUVIO, Sotyktu, Winlevi.
Industry payments across RI — which companies pay providers there.
